Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy: Experimental dermatology • Original article

Clinical and Experimental Dermatology

Volumn 35, Issue 4, 2010, Pages 409-416

  Barahmani, N ^a   Lopez, A ^b   Babu, D ^a   Hernandez, M ^b   Donley, S E ^a   Duvic, M ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALOPECIA AREATA; ARTICLE; ATOPY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TH1 CELL; TH2 CELL;

ADULT; ALOPECIA AREATA; CYTOKINES; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERFERON-GAMMA; INTERLEUKINS; MALE; MIDDLE AGED; PHENOTYPE; TH1 CELLS; TH2 CELLS;

EID: 77951246575     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03523.x     Document Type: Article

References (25)

1. Wiesner-Menzel L, Happle R. Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata. Arch Dermatol Res 1984 276 : 333 334. (Pubitemid 14088195)
2. McElwee KJ, Yu M, Park SW et al. What can we learn from animal models of alopecia areata? Dermatology 2005 211 : 47 53. (Pubitemid 40911564)
3. Safavi KH, Muller SA, Suman VJ et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995 70 : 628 633.
4. Shapiro J. Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin 1993 11 : 611 617. (Pubitemid 23229741)
5. Yoshino T, Asada H, Ando Y et al. Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy. Br J Dermatol 2001 145 : 415 421. (Pubitemid 32953697)
6. Hoffmann R, Wenzel E, Huth A et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994 103 : 530 533. (Pubitemid 24314840)
7. Gilhar A, Landau M, Assy B et al. Transfer of alopecia areata in the human scalp graft/Prkdc (scid) (SCID) mouse system is characterized by a Th1 response. Clin Immunol 2003 106 : 181 187. (Pubitemid 36432115)
8. Ikeda T. A new classification of alopecia areata. Dermatologica 1965 131 : 421 445.
9. Callard RE, Harper JI. The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells? Trends Immunol 2007 28 : 294 298. (Pubitemid 46964900)
10. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol 1996 76 : 421 423. (Pubitemid 26398084)
11. McElwee KJ, Hoffmann R. Alopecia areata - animal models. Clin Exp Dermatol 2002 27 : 410 417. (Pubitemid 34989245)
12. Katagiri K, Arakawa S, Hatano Y. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis. Arch Dermatol Res 2007 298 : 397 401. (Pubitemid 44912443)
13. Bodemer C, Peuchmaur M, Fraitaig S et al. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000 114 : 112 116. (Pubitemid 30195982)
14. Arca E, Musabak U, Akar A et al. Interferon-gamma in alopecia areata. Eur J Dermatol 2004 14 : 33 6. (Pubitemid 38187095)
15. Duvic M, Norris D, Christiano A et al. Alopecia areata registry: an overview. J Investig Dermatol Symp Proc 2003 8 : 219 221. (Pubitemid 37229097)
16. Kuwano Y, Fujimoto M, Watanabe R et al. Serum chemokine profiles in patients with alopecia areata. Br J Dermatol 2007 157 : 466 473. (Pubitemid 47256100)
17. Bunikowski R, Gerhold K, Bräutigam M et al. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 2001 125 : 344 348. (Pubitemid 34704647)
18. Konstantinova NV, Duong DM, Remenyik E et al. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. J Invest Dermatol 1996 107 : 615 621. (Pubitemid 26338589)
19. Tseng LH, Chen PJ, Lin MT et al. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001 57 : 318 324.
20. Dashash M, Drucker DB, Hutchinson IV et al. Interleukin-1 receptor antagonist gene polymorphism and gingivitis in children. Oral Dis 2007 13 : 308 313. (Pubitemid 46632676)
21. Hoffmann R, Happle R. Does interleukin-1 induce hair loss? Dermatology 1995 191 : 273 275.
22. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998 28 : 2598 2602. (Pubitemid 28362734)
23. Tarlow JK, Clay FE, Cork MJ et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994 103 : 387 390. (Pubitemid 24329762)
24. Barahmani N, de Andrade M, Slusser J et al. Interleukin-1 receptor antagonist allele 2 and familial alopecia areata. J Invest Dermatol 2002 118 : 335 337. (Pubitemid 34158490)
25. Brand U, Bellinghausen I, Enk AH et al. Allergen-specific immune deviation from a TH2 to a TH1 response induced by dendritic cells and collagen type I. J Allergy Clin Immunol 1999 104 : 1052 1059. (Pubitemid 29532128)